Methodological Guidelines of the Scientific Community for Human Microbiome Research (CHMR) and the Russian Gastroenterology Association (RGA) on the Use of Probiotics, Prebiotics, Synbiotics, Metabiotics and Functional Foods Enriched with Them for the Treatment and Prevention of Gastrointestinal Diseases in Adults and Children
В. Т. Ивашкин, А.В. Горелов, Д. И. Абдулганиева, O. P. Alexeeva, С. А. Алексеенко, A. Yu. Baranovsky, И. Н. Захарова, O. Yu. Zolnikova, К. В. Ивашкин, N. Yu. Ivashkina, N. V. Korochanskaya, С. Н. Маммаев, С.В. Николаева, Elena Poluektova, А. С. Трухманов, Д.В. Усенко, И. Б. Хлынов, В. В. Цуканов, О. С. Шифрин, I. V. Berezhnaya, Т. Л. Лапина, Roman Maslennikov, Narine G. Sugian, A. I. Ulyanin
Abstract
Aim: to optimize outcomes of the treatment and prevention of gastrointestinal diseases in adults and children. Key points. The Methodological Guidelines contain sections on the terminology, classification, mechanisms of action, requirements for sale in the Russian Federation, requirements for proving the efficacy and safety of probiotics, prebiotics, synbiotics and metabiotics, as well as functional foods enriched with them. An overview of relevant data allowing to include these drugs and products in the treatment an d prevention of gastrointestinal diseases in adults and children is presented. Conclusion. The clinical efficacy of probiotics, prebiotics, synbiotics and metabiotics depends on the specificity and quantity of their components, the dosage form, the regimen and duration of treatment. Products and functional foods with proven efficacy and safety are recommended for the treatment and prevention of gastrointestinal diseases in adults and children.